Guardant Health revenue and financials
In the fiscal year ended December 2025, Guardant Health reported revenue of $982.02M (+32.88% year over year). The net loss was $416.28M.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +32.88%
- 2025 vs 2024
- Net margin
- -42.4%
- 2024: -59.0%
How Guardant Health is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 27.9% a year on average over the last 5 years
Compound annual growth rate: from $286.73M in 2020 to $982.02M in 2025.
Revenue has grown for 9 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin rose from −121.1% to −44.4%
Operating income over revenue, 2022 → 2025: 76.7 percentage points.
Shares outstanding up 28.6% in 5 years
Average diluted shares, 2020 → 2025: with more shares, each one represents a smaller stake in the company (dilution).
Profitable in 0 of 5 fiscal years
Positive net income, fiscal years 2021–2025.
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 982 | 739 | 564 | 450 | 374 | 287 | 214 | 90.6 | 49.8 | 25.2 |
| Cost of revenue | 349 | 290 | 227 | 156 | 123 | 92.5 | 70.7 | 43.2 | 31.6 | 22.1 |
| Gross profit | 633 | 449 | 337 | 293 | 251 | 194 | 144 | 47.4 | 18.2 | 3.1 |
| Selling, general and administrative | 705 | 544 | 451 | 464 | 399 | 299 | 140 | 89.7 | 66.3 | 36.1 |
| Research and development | 364 | 348 | 367 | 374 | 263 | 150 | 86.3 | 50.7 | 25.6 | 10.9 |
| Operating income | -436 | -443 | -481 | -544 | -411 | -255 | -82.4 | -92.9 | -73.6 | -43.8 |
| EBIT | -436 | -443 | -481 | -544 | -411 | -255 | -82.4 | -92.9 | -73.6 | -43.8 |
| EBITDA | -397 | -400 | -438 | -508 | -389 | -239 | -71.0 | -85.8 | -68.4 | -40.2 |
| Interest expense | 3.9 | 2.6 | 2.6 | 2.6 | 2.6 | 4.8 | 1.2 | 1.3 | 2.7 | 3.0 |
| Pre-tax income | -418 | -435 | -479 | -653 | -384 | -246 | -69.7 | -84.2 | -83.2 | -46.1 |
| Income tax | -1.3 | 1.3 | 0.7 | 1.1 | 0.3 | 0.4 | -1.9 | 0.0 | 0.0 | 0.0 |
| Net income | -416 | -436 | -479 | -655 | -406 | -254 | -75.7 | -85.1 | -83.2 | -46.1 |
| Net income to common shareholders | -416 | -436 | -479 | -655 | -406 | -254 | -75.7 | -85.1 | -89.0 | -46.1 |
| Basic EPS | -3.32 | -3.56 | -4.28 | -6.41 | -4.00 | -2.60 | -0.84 | -2.80 | -7.07 | -3.53 |
| Diluted EPS | -3.32 | -3.56 | -4.28 | -6.41 | -4.00 | -2.60 | -0.84 | -2.80 | -7.07 | -3.53 |
| Average shares (basic) | 125 | 123 | 112 | 102 | 101 | 97.5 | 90.6 | 30.4 | 12.6 | 13.1 |
| Average shares (diluted) | 125 | 123 | 112 | 102 | 101 | 97.5 | 90.6 | 30.4 | 12.6 | 13.1 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 335 | 302 | 281 | 265 | 232 | 203 | 202 | 191 | 177 | 168 | 155 | 143 |
| Cost of revenue | 116 | 105 | 99.5 | 93.6 | 81.2 | 74.7 | 77.6 | 74.5 | 72.4 | 65.3 | 62.5 | 57.6 |
| Gross profit | 219 | 197 | 182 | 172 | 151 | 129 | 124 | 117 | 105 | 103 | 92.5 | 85.4 |
| Selling, general and administrative | 251 | 227 | 204 | 181 | 170 | 151 | 156 | 147 | 122 | 119 | 117 | 105 |
| Research and development | 96.5 | 91.0 | 98.3 | 90.0 | 87.4 | 88.5 | 93.5 | 87.3 | 83.1 | 83.8 | 89.9 | 93.9 |
| Operating income | -128 | -121 | -121 | -98.9 | -106 | -111 | -126 | -117 | -100 | -99.6 | -114 | -113 |
| EBIT | -128 | -121 | -121 | -98.9 | -106 | -111 | -126 | -117 | -100 | -99.6 | -114 | -113 |
| EBITDA | -119 | -112 | -111 | -89.5 | -96.1 | -100 | -115 | -106 | -89.7 | -88.9 | -103 | -102 |
| Interest expense | 1.3 | 3.1 | 1.2 | 0.9 | 1.0 | 1.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 |
| Pre-tax income | -120 | -112 | -130 | -92.6 | -99.9 | -94.9 | -110 | -108 | -102 | -115 | -188 | -85.6 |
| Income tax | 0.2 | 0.4 | -1.7 | 0.1 | 0.0 | 0.3 | 0.7 | 0.0 | 0.1 | 0.4 | -0.5 | 0.5 |
| Net income | -120 | -112 | -128 | -92.7 | -99.9 | -95.2 | -111 | -108 | -103 | -115 | -187 | -86.1 |
| Net income to common shareholders | -120 | -112 | -128 | -92.7 | -99.9 | -95.2 | -111 | -108 | -103 | -115 | -187 | -86.1 |
| Basic EPS | -0.90 | -0.85 | -1.00 | -0.74 | -0.80 | -0.77 | -0.90 | -0.88 | -0.84 | -0.94 | -1.58 | -0.73 |
| Diluted EPS | -0.90 | -0.85 | -1.00 | -0.74 | -0.80 | -0.77 | -0.90 | -0.88 | -0.84 | -0.94 | -1.58 | -0.73 |
| Average shares (basic) | 133 | 131 | 129 | 125 | 124 | 124 | 124 | 123 | 122 | 122 | 119 | 118 |
| Average shares (diluted) | 133 | 131 | 129 | 125 | 124 | 124 | 124 | 123 | 122 | 122 | 119 | 118 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2,014 | 1,486 | 1,786 | 1,610 | 2,204 | 2,272 | 963 | 587 | 343 | 117 |
| Current assets | 1,466 | 1,055 | 1,347 | 1,192 | 1,114 | 1,888 | 597 | 469 | 243 | 103 |
| Cash and equivalents | 378 | 526 | 1,134 | 142 | 492 | 833 | 143 | 141 | 72.3 | 33.6 |
| Short-term investments | 823 | 314 | 35.1 | 870 | 441 | 962 | 380 | 278 | 149 | 61.7 |
| Receivables | 138 | 110 | 88.8 | 97.3 | 97.7 | 53.3 | 48.0 | 35.7 | 12.8 | 3.5 |
| Inventory | 85.9 | 71.1 | 61.9 | 51.6 | 30.7 | 22.7 | 15.2 | 9.1 | 7.3 | 2.8 |
| Net property, plant and equipment | 305 | 279 | 303 | 342 | 314 | 100 | 72.8 | 31.0 | 16.0 | 12.6 |
| Goodwill | 77.3 | 3.3 | 3.3 | 3.3 | 3.3 | 3.3 | 3.3 | — | — | — |
| Other intangible assets | 25.9 | 6.8 | 9.0 | 11.7 | 14.2 | 16.2 | 15.4 | 7.8 | 8.7 | — |
| Long-term investments | 6.5 | 16.1 | 107 | 43.3 | 737 | 247 | 269 | 77.6 | 73.3 | — |
| Current liabilities | 303 | 226 | 206 | 193 | 195 | 66.8 | 72.7 | 46.9 | 19.6 | 14.3 |
| Accounts payable | 54.4 | 38.6 | 51.7 | 68.9 | 38.5 | 7.3 | 16.2 | 10.6 | 5.0 | 3.2 |
| Long-term debt | 1,504 | 1,143 | 1,140 | 1,137 | 1,135 | 806 | — | — | — | 16.5 |
| Total debt | 1,710 | 1,336 | 1,354 | 1,369 | 1,374 | 854 | 40.4 | — | 0.7 | 17.0 |
| Total liabilities | 2,113 | 1,625 | 1,628 | 1,550 | 1,559 | 916 | 115 | 62.5 | 34.3 | 36.9 |
| Total equity (incl. minority) | -99.3 | -140 | 159 | 60.2 | 645 | 1,356 | 848 | 525 | 309 | 79.7 |
| Retained earnings | -2,995 | -2,578 | -2,142 | -1,662 | -1,008 | -607 | -353 | -281 | -196 | -108 |
| Minority interest | — | — | — | — | 0.0 | 57.1 | 49.6 | 41.8 | — | — |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1,912 | 1,915 | 2,014 | 1,277 | 1,332 | 1,344 | 1,486 | 1,539 | 1,609 | 1,705 | 1,786 | 1,797 |
| Current assets | 1,365 | 1,368 | 1,466 | 829 | 883 | 927 | 1,055 | 1,227 | 1,290 | 1,309 | 1,347 | 1,347 |
| Cash and equivalents | 1,053 | 989 | 378 | 580 | 523 | 699 | 526 | 585 | 934 | 1,029 | 1,134 | 457 |
| Short-term investments | 0.0 | 113 | 823 | 0.0 | 0.0 | — | 314 | 342 | 52.5 | — | 35.1 | 697 |
| Receivables | 144 | 137 | 138 | 116 | 130 | 115 | 110 | 88.5 | 101 | 84.6 | 88.8 | 88.8 |
| Inventory | 105 | 83.9 | 85.9 | 90.5 | 84.1 | 77.3 | 71.1 | 72.3 | 67.0 | 63.0 | 61.9 | 77.0 |
| Net property, plant and equipment | 303 | 304 | 305 | 288 | 296 | 270 | 279 | 270 | 278 | 290 | 303 | 309 |
| Goodwill | 77.3 | 77.3 | 77.3 | 3.3 | 3.3 | 3.3 | 3.3 | 3.3 | 3.3 | 3.3 | 3.3 | 3.3 |
| Other intangible assets | 25.3 | 25.5 | 25.9 | 5.5 | 5.9 | 6.3 | 6.8 | 7.3 | 7.7 | 8.3 | 9.0 | 9.7 |
| Long-term investments | 6.5 | 6.5 | 6.5 | 20.1 | 16.1 | 11.1 | 16.1 | 11.1 | 11.1 | 76.5 | 107 | 111 |
| Current liabilities | 339 | 292 | 303 | 237 | 238 | 226 | 226 | 197 | 202 | 220 | 206 | 227 |
| Accounts payable | 93.5 | 75.0 | 54.4 | 20.1 | 44.8 | 49.8 | 38.6 | 15.5 | 42.4 | 37.6 | 51.7 | 77.8 |
| Long-term debt | 1,503 | 1,503 | 1,504 | 1,115 | 1,116 | 1,116 | 1,143 | 1,142 | 1,141 | 1,141 | 1,140 | 1,139 |
| Total debt | 1,697 | 1,705 | 1,710 | 1,326 | 1,334 | 1,306 | 1,336 | 1,339 | 1,341 | 1,347 | — | — |
| Total liabilities | 2,135 | 2,096 | 2,113 | 1,631 | 1,637 | 1,595 | 1,625 | 1,599 | 1,611 | 1,636 | 1,628 | 1,569 |
| Total equity (incl. minority) | -223 | -181 | -99.3 | -354 | -305 | -251 | -140 | -60.1 | -1.6 | 68.3 | 159 | 228 |
| Retained earnings | -3,227 | -3,107 | -2,995 | -2,866 | -2,773 | -2,673 | -2,578 | -2,467 | -2,359 | -2,257 | -2,142 | -1,955 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -185 | -240 | -325 | -309 | -209 | -104 | -47.1 | -72.2 | -72.2 | -36.7 |
| Depreciation and amortization | 39.7 | 42.4 | 42.9 | 36.0 | 22.3 | 16.1 | 11.4 | 7.1 | 5.2 | 3.7 |
| Capital expenditure | -48.3 | -35.1 | -20.5 | -77.5 | -75.0 | -36.2 | -18.7 | -20.2 | -6.7 | -1.8 |
| Investing cash flow | -627 | -261 | 840 | 150 | -63.2 | -617 | -318 | -153 | -170 | 26.2 |
| Financing cash flow | 671 | -1.0 | 477 | -189 | -66.8 | 1,410 | 367 | 293 | 282 | 39.8 |
| Share repurchases | -75.5 | -15.7 | -11.2 | -7.9 | -83.8 | -3.4 | 0.0 | -0.2 | -7.2 | -0.1 |
| Debt issued | 403 | 0.0 | 0.0 | 0.0 | — | 1,133 | — | — | — | 0.0 |
| Debt repaid | — | — | — | -0.1 | -0.1 | -0.2 | -0.1 | -0.4 | -26.1 | -0.4 |
| Effect of exchange rates | 0.5 | -1.8 | -0.9 | -1.6 | -1.7 | 0.5 | 0.1 | — | — | — |
| Net change in cash | -140 | -504 | 992 | -350 | -341 | 690 | 2.7 | 67.9 | 39.0 | 29.3 |
| Free cash flow | -233 | -275 | -345 | -387 | -284 | — | — | — | — | — |
| Levered free cash flow | -88.1 | -149 | -181 | -296 | -123 | -75.8 | -51.0 | -66.0 | -56.3 | — |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -57.8 | -65.6 | -26.4 | -35.4 | -60.3 | -62.7 | -64.5 | -51.1 | -94.0 | -30.3 | -78.7 | -77.8 |
| Depreciation and amortization | 9.6 | 9.4 | 10.1 | 9.4 | 10.0 | 10.2 | 10.5 | 10.6 | 10.6 | 10.7 | 10.9 | 11.0 |
| Capital expenditure | -11.8 | -5.6 | -27.8 | -10.4 | -5.6 | -4.5 | -18.9 | -4.2 | -5.1 | -6.9 | -4.1 | -2.4 |
| Investing cash flow | 101 | 699 | -905 | -14.4 | -10.6 | 303 | 10.5 | -295 | -5.1 | 28.1 | 663 | 261 |
| Financing cash flow | 23.0 | -21.6 | 732 | 4.3 | 1.6 | -66.9 | -2.9 | -2.9 | 5.9 | -1.1 | 90.6 | 3.8 |
| Share repurchases | -8.3 | -20.7 | -5.4 | -2.3 | -7.4 | -60.5 | -8.0 | -2.9 | -3.2 | -1.5 | -3.1 | -3.0 |
| Debt issued | 0.0 | 0.0 | 397 | 5.0 | 0.0 | — | — | — | — | — | — | — |
| Effect of exchange rates | -0.4 | -0.2 | -0.7 | -0.5 | 0.9 | 0.8 | -1.7 | 1.9 | -0.8 | -1.1 | 1.0 | -0.5 |
| Net change in cash | 66.3 | 612 | -200 | -46.0 | -68.4 | 174 | -58.6 | -347 | -94.0 | -4.4 | 676 | 186 |
| Free cash flow | -69.5 | -71.2 | -54.2 | -45.8 | -65.9 | -67.1 | -83.4 | -55.3 | -99.1 | -37.2 | -82.8 | -80.2 |
| Levered free cash flow | -24.7 | -37.5 | -1.8 | 89.6 | -136 | -40.2 | 60.0 | -17.2 | -72.8 | -119 | -48.9 | -35.2 |
Financial statements of similar companies
Companies in the group: same industry, similar size
